Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today: Donate
Dr. Sabine Mai
Manitoba Institute of Cell Biology, Winnipeg, MB
The proposed study focuses on ependymoma, a childhood brain tumour. At diagnosis, it is not possible to know which child will respond to treatment and which child will recur, i.e. if prognosis is favourable or non-favourable. We have developed quantitative tools that may allow for the distinction of good and poor responders at diagnosis.
These tools involve three-dimensional (3D) imaging of telomeres. Telomeres are the ends of chromosomes; they protect the chromosomes from damage and prevent recombination and fusion with other chromosomes (Mai, 2010). Telomere dysfunction therefore is associated with genomic instability and found in many cancers (Mai and Garini, 2006; Mai, 2010).
The data obtained in this study are quantitatively measured, and the output is expected to be a 3D nuclear telomeric profile of each child’s tumour, indicative of favourable or non-favourable disease and will, in the near future, enable for the first time a choice for specific treatments for each child’s ependymoma.
Donna hopes she’s at a curve in the road. It’s been a long road since the diagnosis of a non-malignant brain tumour that has been treated with surgery, chemotherapy and radiation. “I never thought I would have to go through all this for a tumour that wasn’t cancerous” said Donna. This is her story.Learn more
May 15, 2016 is D.I.P.G. Awareness Day in the Province of British Columbia. Sevanah's parents shared Sevanah's story of grace and faith...Learn more
This Mother's Day we are sharing this Mother's wish for a future with no brain tumours! In her own words, she shares her son Kohen's...Learn more